信号调节蛋白β2是一种新型的抗癌免疫的新型积极调节剂
Nienke Visser1, Levi Collin Nelemans1, Yuan He1
1Department of Hematology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, Netherlands.
Frontiers in immunology
|December 20, 2023
概括
信号调节蛋白β2 (SIRP-β2) 是一种新的免疫激活剂. 这种蛋白质通过促进癌细胞化和T细胞激活来增强先天抗癌免疫力,提供了一个新的免疫治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 治疗针对天生的抗癌免疫力,例如阻断SIRP-α/CD47相互作用,在淋巴瘤治疗中显示出希望.
- SIRP-α 抑制了细胞,有助于癌细胞的免疫逃逸.
- 该SIRP家族包括抑制和刺激受体.
研究的目的:
- 为了研究未经表征的SIRP家族成员SIRP-β2 (SIRP-β2) 在先天抗癌免疫中的作用.
- 确定SIRP-β2的表达模式和对免疫细胞的功能影响.
主要方法:
- 在巨细胞和粒细胞中评估SIRP-β2蛋白表达.
- 相关的内源性SIRP-β2表达在癌细胞巨细胞症的粒细胞上.
- 研究了宫外SIRP-β2表达对巨细胞功能 (粘附,分化,细胞) 和T细胞激活的影响.
- 研究了SIRP-ß2与DAP12的相互作用以及 lysine 202在这种相互作用中的作用.
主要成果:
- 在巨细胞和粒细胞中,SIRP-β2的表达很高.
- 内源性SIRP-β2在粒细胞上的表达与癌细胞巨细胞形成相关.
- 异位SIRP-β2表达增强了巨细胞的粘附,分化和癌细胞的细胞化.
- 通过巨细胞介导的途径激活SIRP-ß2增强的T细胞.
- SIRP-β2通过素202招募DAP12,这对其刺激作用至关重要.
结论:
- SIRP-ß2 是一种新型的抗癌免疫的新型积极调节剂.
- 通过招募DAP12来增强免疫细胞活性,SIRP-β2的功能.
- SIRP-β2是开发新型先天免疫疗法的潜在辅助刺激标.
相关概念视频
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


